Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© 2013 EFORT. All rights are reserved. Metal-on-metal hip resurfacing arthroplasty (MoMHRA) was introduced in 1997 and has become an established surgical option, especially for younger patients with end-stage osteoarticular disease (Daniel et al. 2011). Designer and non-designer data continue to support the use of MoMHRA for this cohort of patients despite pseudotumour becoming an acknowledged complication (Murray et al. 2012; Treacy et al. 2011). The rates of pseudotumour are variable, and concern amongst the general public, healthcare providers and government is increasing together with the potential revision burden on hip services particularly compounded by poor reported outcomes post-revision (Glyn-Jones et al. 2009; Pandit et al. 2008; Hart et al. 2009; Kwon et al. 2011; Grammatopolous et al. 2009; Carrothers et al. 2010).

Original publication

DOI

10.1007/978-3-642-35653-7_8

Type

Chapter

Book title

Total Hip Arthroplasty: Tribological Considerations and Clinical Consequences

Publication Date

01/12/2013

Pages

75 - 83